Buy GSK Consumer; target of Rs 6102: ICICI Direct
ICICI Direct is bullish on GSK Consumer has recommended buy rating on the stock with a target price of Rs 6102 in its research report dated February 14, 2017.
ICICI Direct's research report on GSK Consumer
We are estimating 12.4% CAGR in the revenue in FY17E-19E and 11.6% CAGR in PAT during the same period. We value the stock at 30x its FY19E EPS of Rs 200.1 and arrive at a target price of Rs 6102/share with a BUY recommendation on the stock.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.